PGI18 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPE I CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
May 1, 2010, 00:00
10.1016/S1098-3015(10)72337-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)72337-8/fulltext
Title :
PGI18 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPE I CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72337-8&doi=10.1016/S1098-3015(10)72337-8
First page :
Section Title :
Open access? :
No
Section Order :
939